Title : Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes.

Pub. Date : 2003 Apr

PMID : 12649382






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gabexate mesilate, a synthetic protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappaB and activator protein-1 in human monocytes. Gabexate tumor necrosis factor Homo sapiens
2 Gabexate mesilate, a synthetic protease inhibitor, was shown to be effective in treating patients with sepsis-associated disseminated intravascular coagulation in which tumor necrosis factor-alpha (TNF-alpha) plays a critical role. Gabexate tumor necrosis factor Homo sapiens
3 Gabexate mesilate, a synthetic protease inhibitor, was shown to be effective in treating patients with sepsis-associated disseminated intravascular coagulation in which tumor necrosis factor-alpha (TNF-alpha) plays a critical role. Gabexate tumor necrosis factor Homo sapiens
4 In the present study, we analyzed the mechanism(s) by which gabexate mesilate inhibits LPS-induced TNF-alpha production in human monocytes in vitro. Gabexate tumor necrosis factor Homo sapiens
5 Gabexate mesilate inhibited the production of TNF-alpha in monocytes stimulated with LPS. Gabexate tumor necrosis factor Homo sapiens
6 These observations strongly suggest that gabexate mesilate inhibited LPS-induced TNF-alpha production in human monocytes by inhibiting activation of both NF-kappaB and AP-1. Gabexate tumor necrosis factor Homo sapiens
7 Inhibition of TNF-alpha production by gabexate mesilate might explain at least partly its therapeutic effects in animals given LPS and those in patients with sepsis. Gabexate tumor necrosis factor Homo sapiens